Gene transfer into hemopoietic stem cells could offer a lasting cure for a variety of congenital disorders.
the infected bone marrow could be conserved, suggting survival of repopulating hemopoietic stem cells. In the hemopoietic system of transplanted animals the foreign gene could be observed for as long as the animals were analyzed (in two monkeys >1 yr after transplantation). Genetically modified cell types and tissues included peripheral blood mononuclear cells, granulocytes, bone-marrow cells of various densities, and spleen and lymph nodes. The presence of the provirus in the short-living granulocytes >1 yr after bone-marrow transplantation provided evidence for the transduction of very primitive hemopoietic progenitors. Moreover, the gene transfer resulted in sustained production of functional human adenosine dminase enzyme in peripheral blood mononuclear cells. These results demonstrate the feasibility of bone-marrow gene-therapy approaches, in particular for treating adenosine deaminase deficiency.
Retrovirus-mediated gene transfer into transplantable cells can potentially be used for the treatment of many disorders (1, 2) . Ofthese, inherited immunodeficiency due to adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) deficiency is the paradigm. The ultimate target cell in such a gene-therapy procedure would be the pluripotent hemopoietic stem cell (PHSC) present in bone marrow because of its lasting capacity to generate a complete hemopoietic system. Transfer of the human ADA (hADA) gene into PHSC has already been accomplished in mice with retroviral vectors (3) (4) (5) (6) (7) . For such procedures to become clinically acceptable, results obtained in mice need to be confirmed in a relevant preclinical model. To this end, we have developed an autologous bone-marrow transplantation (BMT) model in rhesus monkeys by using genetically modified bone-marrow cells (BMC) . Studies in this model will answer questions concerning (i) the quality of in vitro-manipulated bone-marrow grafts, and (ii) the infectibility of primate PHSC. So far, attempts to transfer genes into primate PHSC have met with only moderate success (8) (9) (10) . Gene transfer by cocultivating primate BMC with retrovirus-producing cell lines was associated with an inability to reconstitute the hemopoietic system upon autologous transplantation. As a result, only few monkeys survived >100 days after BMT. None of these surviving monkeys showed any sign ofgenetic modification in vivo (8) . After gene transfer by virus supernatant infection (8, 9 ) the hemopoietic system of the monkeys could be repopulated. However, it could not be excluded that the transient genetic modification observed in some ofthese animals was the result of infection of long-living T lymphocytes. Furthermore, interpretation of these studies was troublesome because the viruses used were contaminated with replication-competent viruses. In fact, gene transfer was not observed in the absence of replication-competent viruses (10) .
To solve the problems that have hampered success in primate bone-marrow gene therapy studies so far, we set out to define culture conditions that allow retroviral vectormediated gene transfer into primate PHSC without significantly affecting their ability to reconstitute the hemopoietic system.
MATERIALS AND METHODS
Bone-Marrow Processing. Bone-marrow aspirations, obtained by puncturing femoral shafts under total anesthesia, were suspended in Hepes-buffered Hanks' basic salt solution containing heparin at 100 units per ml and deoxyribonuclease I at 100 pyg/ml and subjected to Ficoll gradient separation. BMC were enriched for stem cells by discontinuous bovine serum albumin density-gradient centrifugation, essentially as described (11) . Cells with a specific gravity of <1.064 g/cm3 were suspended at 106 cells per ml in high-glucose (4.5 g/liter) a-modified Dulbecco's medium, supplemented with 5% heatinactivated monkey serum; bovine serum albumin at 15 mg/ml; 12.5 uM Na2SeO3; iron-saturated human transferin at 0.6 mg/ml; nucleosides adenosine, 2'-deoxyadenosine, guanosine, 2'-deoxyguanosine, cytidine, 2'-deoxycytidine, thymidine, and uridine each at 1 pg/ml; 15 JM linoleic acid; 15 pM cholesterol; 100 pM 2-mercaptoethanol; Polybrene at 0.4 pg/ml; streptomycin at 100 pg/ml; penicillin at 100 units per ml; and the hemopoietic growth factors human interleukin la (hIL-la) (provided by Immunex, Seattle) and/or rhesus monkey interleukin 3 (RhIL-3) (12 tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 7641 ministration of antimicrobial agents. The monkeys were first treated with metronidazole (40 mg/kg per day) during 5 days, and subsequently a combination of ciprofloxacin (provided by Bayer, Leverkussen, F.R.G.; 6.5 mg/kg per day), polymyxin B (10 mg/kg per day), and nystatin (40,000 units per monkey per day) was administered daily. Two days and one day before BMT the animals were conditioned for grafting with bilateral total-body x-ray irradiation given in two equal fractions under total anesthesia. Monkeys 1ZW, 8665, and 8703 received a total dose of 15 Gy; all other monkeys were given 13.6 Gy. The lungs were shielded with lead during a fraction of the irradiation time, resulting in a total lung dose of 10.1 Gy for monkeys 1ZW, 8665, and 8703 or 10.6 Gy for all other animals. Bone-marrow grafts were infused into a peripheral vein. Barrier nursing and selective decontamination were maintained until leukocyte counts after BMT exceeded 1 x 109 cells per liter for at least 3 weeks.
Hemopoietic Progenitor Assay. BMC were plated in cocultivation medium as above without Polybrene and monkey serum and with 5% heat-inactivated fetal calf serum, recombinant human granulocyte/macrophage colony-stimulating factor at 250 units per ml, and 0.8% methylcellulose. Colonyforming units in culture (CFU-C)-derived progenitor colonies >50 cells were scored after 9-11 days. CFU-C overexpressing ADA were selected by adding 4,uM xylofuranosyladenine and 3 nM deoxycoformycin to the medium (13) . Recombinant human granulocyte/macrophage colony-stimulating factor, xylofuranosyladenine, and deoxycoformycin were gifts from Behringwerke; the Drug Synthesis and Chemistry Branch, National Cancer Institute (Bethesda, MD); and Parke-Davis, respectively.
PCR and ADA Enzyme Analysis. Blood samples were Ficoll-separated, and subsequently the interphase fraction and the packed cells were individually treated with erythrocyte lysis buffer (155 mM NH4Cl/12 mM NaHCO3/89 AuM EDTA), yielding peripheral blood mononuclear cells (PBMC) and granulocyte samples, respectively. Bone-marrow samples, taken by puncturing femoral or humeral shafts, were separated on bovine serum albumin gradients (11) . T-lymphocyte depletions were performed by erythrocyte-rosetting, essentially done according to Madsen et al. (14) . Autopsy materials were frozen in liquid N2 immediately after dissection.
DNA was isolated by incubating the samples in PCR buffer (10 mM Tris HCl, pH 8.3/50 mM KC1/2.5 mM MgCl2/0.01% gelatin) with 0.5% Nonidet P-40/0.5% Tween 20/proteinase K at 60 ,ug/ml at 55°C for 1 hr (cell pellets) or 16 hr (tissue sections). The proteinase was inactivated at 95°C, and the lysates were cleared by centrifugation. The DNA concentration was measured fluorometrically with 4',6'-diamidino-2'-phenylindole. DNA samples equivalent to 105 cells (690 ng) were denatured and subjected to nested PCR analysis (15) . In the first round, a 396-base-pair sequence was amplified with amplimers 5'-CGGCCAAATCTAGTTTCCTC-3' and 5'-AGTCCCTGTTCCTATTCCAG-3', hybridizing against hADA-cDNA and Moloney murine leukemia virus envelope sequences, in 50 ,ul of PCR buffer containing 200 ,uM of each dNTP, 10 pmol of each primer, and 1.25 units of Taq DNA polymerase (30 cycles of 1.5 min at 94°C, 2 min at 60°C, and 3 min at 72°C). Subsequently, one-tenth of the PCR product was subjected to amplification specific for a 248-base-pair sequence within the amplified fiagment, with amplimers 5'-TATGGGATGCCACCTTCAGC-3' and 5'-GATTCAGC-GCCGACGGGACG-3', hybridizing against hADA-cDNA and noncoding hepatitis B virus sequences. Conditions differing from the first reaction were as follows: 7.5 mM MgCl2 and 50 pmol of ADA primer in the reaction mixture and annealing at 680C. Amplified samples were analyzed by electrophoresis through a 2% agarose gel, stained with ethidium bromide. By repeating the PCR reaction on serial 10-fold dilutions of the positive samples, semiquantitative results were obtained. Each assay included a titration of NIH 3T3 cells carrying a single provirus copy diluted in normal rhesus monkey PBMC. In these titrations, samples containing a single provirus per 690 ng of DNA yielded a specific amplification product in 72% of the performed assays. In all other assays the sensitivity appeared one dilution-step lower, a difference that we attribute to stochastic variation. Reactionmixture controls and normal rhesus monkey PBMC controls that were included in each assay always remained negative.
The presence of functional hADA enzyme in cell lysates was detected by zymogram analysis, essentially as described (16) with Cellogel (Chemetron, Milan).
RESULTS AND DISCUSSION
Hemopoietic Reconstitution with Retrovirus-Infected BMC. Rhesus monkey bone marrow was cocultured for 90 hr with the hADA-virus-producing cell line POC-1 (6). The effects of adding two different hemopoietic growth factors to these cultures was compared. RhIL-3 (12) was added to the medium at either 2 ng/ml or 50 ng/ml. In the third experimental group, we included hIL-la at 10 units per ml in addition to RhIL-3 at 2 ng/ml. These culture conditions were initially tested for their effects on recovery and transduction of hemopoietic progenitors capable of in vitro colony formation (CFU-C) ( Table 1) . Not all of the hemopoietic cells could be recovered as nonadherent cells after coculture, and it appeared that =50%6 of the CFU-C were present in the adherent cell layer (data not shown). This result confirmed a previous observation that primitive hemopoietic cells adhere to fibroblasts (18) . The total CFU-C recovery ranged between 97 and 151%. To quantify hADA gene transfer into CFU-C, the cells were plated in medium selecting for cells overexpressing ADA (13) . All cocultures resulted in transduction of CFU-C. The gene-transfer efficiency seemed highest in cultures with RhIL-3 alone (Table 1) .
Next, the capacity of the infected cells to reconstitute the hemopoietic system was measured in vivo after autologous transplantation. To prevent loss of PHSC the adherent cells were included in the graft. One monkey (1ZW) was grafted with nonadherent cells only. A dramatic loss of repopulating capacity during in vitro culture was only observed in one of two monkeys receiving BMC cultured with both hIL-la and RhIL-3. In all monkeys that received BMC cultured with RhIL-3, regeneration patterns indicated that repopulating capacity of the graft could be conserved (ref. 17; Table 1 ). Moreover, all animals repopulated their lymphoid, myeloid, erythroid, and thrombocytic lineages. This result contrasts sharply with the previously reported failures to repopulate the primate hemopoietic system after autologous transplantation of cocultured BMC (8-10). The successful hemopoietic reconstitution in our study could be the result of applying species-specific RhIL-3 (12), which was not available to earlier studies. Alternatively, it could be explained by poorly understood differences between virus-producing cell lines. Despite the fact that all packaging cell lines are derived from NIH 3T3 cells, inherent differences between various subclones with respect to, for example, growth factor production could be envisaged. In fact, when several packaging cell lines were studied for their production of interleukin 6, large differences were seen (19) .
The procedure of gene transfer did not result in any clinical, biochemical, or hematological changes indicative of toxicity that could not be attributed to postirradiation changes seen in routine BMT. To assess the possible occurrence of delayed effects of the gene-transfer procedure, several monkeys from this study will remain under long-term surveillance. Sustd Genetic Modification ofRhesus Monkey Hemopoietic Cells After Autologous Transplantation of Infected BoneMarrow Grafts. After hemopoietic reconstitution, the presence of hADA-proviruses was monitored in PBMC and in granulocytes. DNA isolated from these cells was subjected to nested PCR analysis specific for the provirus; sensitivity of this procedure is one provirus copy in 105 negative cells. The frequency of provirus-carrying cells was estimated by analyzing dilutions of PCR-positive samples. Fig. 1 shows an example of such an analysis (granulocytes from monkey 8665). Results of PCR analyses on all seven experimental animals are gathered in Fig. 2 . When monkeys were transplanted with bone marrow cocultured with both RhIL-3 and hIL-la, significant numbers of PCR-positive cells were only detected during a short period after BMT. After 112 days, no provirus-carrying cells could be detected anymore in either of the two monkeys. Moreover, because little genetic modification was found in the granulocyte fractions, gene transfer seemed restricted to progenitors that give rise to PBMC. In this experimental group, therefore, only quite mature cells became infected. This finding is remarkable because in our studies in mice that led to transduction of PHSC we also added both interleukin 1 and interleukin 3 (6 In the reactions, the amount of DNA equivalent to the number of cells indicated above each lane (cell equivalent) was analyzed.
hIL-la was omitted from the culture medium, long-term multilineage genetic modification was obtained in four offive monkeys. Provirus-positive PBMC and granulocytes remained in the circulation of these monkeys throughout the experiment (at least 102, 123, 367, and 381 days after BMT, see Fig. 2 ). The fact that the granulocyte fractions remained PCR-positive during the entire observation period was particularly important because granulocytes have a half-life in the circulation of only several hours. Hence, these results provide evidence for gene transfer into very early hemopoietic progenitor cells.
From all monkeys bone-marrow samples were also analyzed ( (16) . Because zymograms are only moderately sensitive, expression analysis on nucleated cells was not attempted unless the provirus frequency in these cells approached 1%. Fig. 2 
